Engender Technologies
Auckland
About Engender Technologies
Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively license Engender’s technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: M&A
- Last round: Grant (Aug 2022)
- Website: engendertechnologies.com
- Phone: 64 9 304 0865
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/engender-technologies-69631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.